Hunter Land

• Navigating the differences in the regulatory landscape for botanical and synthetic drugs
• Discussing how research into both fields has contributed to the overall understanding of cannabinoid pharmacology
• Validating effectively scaling up in synthetic drug production versus maintaining API consistency in botanical drugs

• Discussing preclinical and clinical data from equine studies demonstrating cartilage growth using CBD – corticosteroid combination therapeutics and insights into patient clinical trials for Crohn’s disease
• Exploring rational polypharmacy and the strategic drug combination methodologies aimed to reduce individual drug dosage whilst maintaining or enhancing therapeutic effect
• Analyzing dosing versus formulation and their significance on the pharmacokinetic and principles for combination drugs

NEW DATA